Windtree Therapeutics WINT Income Statement (2010-2025)

OTC WINT
$0.00 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT
Reported Financials

Windtree Therapeutics Quarterly Income Statement

Periods 61 quarters
Latest Sep 2025

Windtree Therapeutics reported net income of -$28.09M for the quarter ended Sep 2025. This income statement covers 61 quarters of results from Sep 2010 through Sep 2025, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue
Cost of RevenueCost of Rev
Gross Profit
Operating items
Research & DevelopmentR&D
3.54M4.41M4.22M4.68M4.48M5.35M3.00M1.54M1.22M1.42M1.76M2.11M3.05M2.25M9.86M1.97M2.19M2.27M2.18M1.90M
Selling, General & AdministrativeSG&A
3.43M4.67M3.37M3.47M2.97M2.99M2.91M2.65M2.24M2.29M2.42M2.58M1.91M2.15M1.59M2.77M2.23M1.82M1.80M1.86M
Other Operating ExpensesOther Opex
37.77M7.25M11.64M0.45M7.35M0.48M2.57M1.12M16.13M
Operating ExpensesOpex
6.96M9.08M45.36M8.15M14.69M8.33M17.54M4.65M10.81M4.19M6.76M4.69M4.96M4.41M11.45M4.74M5.54M4.09M3.98M19.88M
Operating IncomeOp. Inc
-6.96M-9.08M-45.36M-8.15M-14.69M-8.33M-17.54M-4.65M-10.81M-4.19M-6.76M-4.69M-4.96M-4.41M-11.45M-4.74M-5.54M-4.09M-3.98M-19.88M
EBIT
-6.96M-9.08M-45.36M-8.15M-14.69M-8.33M-17.54M-4.65M-10.81M-4.19M-6.76M-4.69M-4.96M-4.41M-11.45M-4.74M-5.54M-4.09M-3.98M-19.88M
Non-operating items
Non Operating Interest Expenses
0.00M0.04M0.05M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.11M0.05M0.06M0.02M0.08M0.33M
Goodwill impairment chargesGoodwill Impair.
11.64M0.50M0.50M0.50M2.60M
Interest & Investment IncomeInt & Inv Inc
0.01M0.05M0.04M0.00M0.00M0.00M0.02M0.04M0.05M0.04M0.11M0.11M0.06M0.03M0.02M0.01M0.01M0.01M0.20M0.76M
Other Non Operating IncomeOther Non Op Inc.
-0.50M0.11M-0.35M-0.05M-0.02M0.22M0.20M0.57M-0.29M0.05M0.06M0.17M-0.24M14.72M-0.29M-2.54M-8.37M-0.21M-0.45M0.77M
Non Operating IncomeNon Op. Inc.
-0.49M0.12M-0.36M-0.07M-0.04M0.21M0.21M0.59M-0.25M0.08M0.16M0.27M-0.20M14.74M-0.38M1.75M8.23M0.05M-6.65M-11.63M
Net income details
EBT
-7.45M-9.07M-45.72M-8.21M-14.73M-8.35M-17.33M-4.06M-11.06M-4.11M-6.60M-4.43M-5.15M10.33M-11.83M-2.99M2.69M-4.05M-10.63M-31.52M
Tax ProvisionsTaxes
-8.33M-1.66M-1.37M0.11M0.20M-0.24M-0.11M-3.43M
Profit After TaxPAT
-7.45M-9.07M-37.39M-8.21M-13.07M-8.35M-17.33M-4.06M-9.69M-4.11M-6.60M-4.43M-5.15M10.22M-12.03M-2.75M2.80M-4.05M-10.63M-28.09M
Income from Continuing OperationsIncome (Continuing)
-7.45M-9.07M-37.39M-8.21M-13.07M-8.35M-17.33M-4.06M-9.69M-4.11M-6.60M-4.43M-5.15M10.22M-12.03M-2.75M2.80M-4.05M-10.63M-28.09M
Consolidated Net IncomeConsol Net Inc.
-7.45M-9.07M-37.39M-8.21M-13.07M-8.35M-17.33M-4.06M-9.69M-4.11M-6.60M-4.43M-5.15M10.22M-12.03M-2.75M2.80M-4.05M-10.63M-28.09M
Income towards Parent CompanyParent Net Inc
-7.49M-8.96M-37.39M-8.21M-13.04M-8.13M-17.33M-4.10M-9.69M-4.11M-6.60M-4.43M-5.16M10.22M-12.02M-2.75M2.80M-4.05M-10.63M-28.10M
Preferred Dividend PaymentsPref Dividends
-0.57M4.19M1.00M4.28M
Net Income towards Common StockholdersNet Income
-7.49M-8.96M-37.39M-8.21M-13.04M-8.13M-17.33M-4.10M-9.69M-4.11M-6.60M-4.43M-5.15M10.22M-12.02M-3.75M0.07M-5.04M-14.92M-28.94M
Additional items
EPS (Basic)
-8.61-9.11-25.54-5.54-9.48-5.17-10.68-2.37-276.89-85.74-29.48-15.47-23.9321.98-20.91-4.231.29-4.63-3.06-1.08
EPS (Diluted)
-89.99-107.69-449.33-98.70-156.66-97.67-208.30-49.27-116.48-49.41-79.33-53.18-61.94122.81-144.50-45.070.82-60.61-179.28-347.77
Shares Outstanding
0.87M0.98M1.46M1.48M1.38M1.57M1.62M1.73M0.04M0.05M0.22M0.29M0.22M0.47M0.58M0.89M0.05M1.09M4.88M26.68M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
0.94M0.98M1.48M1.57M1.57M1.63M1.70M1.73M0.04M0.05M0.22M0.29M0.22M0.47M0.59M0.89M0.05M1.09M4.88M26.68M
EBITDA
-6.89M-9.03M-45.31M-8.10M-14.63M-7.93M-17.45M-4.63M-10.79M-4.17M-6.73M-4.68M-4.92M-4.38M-11.43M-4.69M-5.50M-4.07M-3.97M-19.34M
Interest ExpensesInt Expense
0.00M0.04M0.05M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.11M0.05M0.06M0.02M0.08M0.33M
Tax Rate
1.10%

Windtree Therapeutics Income Statement API

Pull Windtree Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=WINT&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY